Basic information
Biomarker: mesothelin
Histology type: endometrial serous carcinomas
Cohort characteristics
Country: Japan
Region: Saitama
Followed up time :
Subgroup 1 name : Positive
Subgroup 1 number: 19
Subgroup 2 name: Negative
Subgroup 2 number: 21
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
40 | EC | 40 |
Sample information
Conclusion: Co-expression of mesothelin and CA125 may accurately predict OS in endometrial serous carcinoma .
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : co-Expression of Mesothelin ( ≥50% (proportion score 3+) and the entire circumference of the cancer cell membrane is stained (intensity score 2+))and CA125 (The percentage of CA125-positive cells is ≥50% (proportion score 3+) and the cytoplasm of cancer cell is highly stained (intensity score 2+))
Expression elevation: The percentage of mesothelin- or CA125-positive cells in carcinoma tissues, was as follows:1+, ≥1% and < 10%; 2+, ≥10%and < 50%; and 3+, ≥50% cells stained in entire carcinoma tissue. Staining intensity score is defined as follows: 1+, incomplete membrane staining and/or faint or barely perceptible cytoplasmic staining detected; and 2+, entire circumference of the cell membrane stained and/or moderate to strong cytoplasmic staining. Additionally, a proportion score of 3+ and/or staining intensity score of 2+ was considered as positive mesothelin or CA125 expression.
Disease information
Statictics: cutoff<65;cutoff>65
Subgroup 1 age: 12;7
Subgroup 2 age: 12;9
Related information
Funtion Uniprot: Membrane-anchored forms may play a role in cellular adhesion. Megakaryocyte-potentiating factor (MPF) potentiates megakaryocyte colony formation in vitro.
UniProt ID: Q13421
UniProt Link: https://www.uniprot.org/uniprotkb/Q13421/entry#function
Biological function from UniProt: Cell adhesion
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in lung. Expressed at low levels in heart, placenta and kidney. Expressed in mesothelial cells. Highly expressed in mesotheliomas, ovarian cancers, and some squamous cell carcinomas (at protein level).
Subcellular UniProt: #Cell membrane #Golgi apparatus #Membrane #Secreted
Alternative name from UniProt:
Recommended name: Mesothelin
Gene name from HGNC: MSLN (CAK1, MPF)
HPA class: Located in Nucleoplasm, Vesicles
AlphaFold DB: Q13421
AlphaFold Link: https://alphafold.ebi.ac.uk/entry/Q13421
HPA link: https://www.proteinatlas.org/ENSG00000102854-MSLN
Tissue specificity RNA from HPA: Tissue enhanced (adipose tissue, fallopian tube)
Tissue expression from HPA: Cytoplasmic and membranous expression in squamous epithelia and glandular cells of cervix and fallopian tube.
Single cell type specificity Cell type enhanced (Paneth cells, Alveolar cells type 1, Club cells, Alveolar cells type 2, Glandular and luminal cells)
Immune cell specificity: Respiratory epithelial cells - Mucosal defense (mainly)
Subcellular summary HPA Located in Nucleoplasm, Vesicles
Cancer prognostic summary HPA Prognostic marker in renal cancer (favorable) and pancreatic cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000102854-MSLN/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000102854-MSLN/pathology/endometrial+cancer
Disease: No disease ID
Note1: Antibodies against MSLN are detected in patients with mesothelioma and ovarian cancer
OMIM: 601051
OMIM link2: https://www.omim.org/entry/601051
HGNC ID: HGNC:7371
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:7371